Developer docs
API playgroundTry for free, no card

Search company profiles

Grey Wolf Animal Health

Full company profile

uuid0008m55

Namestring
Grey Wolf Animal Health
Legal namestring
Grey Wolf Animal Health Inc.
Websiteurl
greywolfah.com
Company typeenum
Public
Founded yearint
2015
Descriptiontext

Grey Wolf Animal Health is a Canadian specialty animal health company that distributes pharmaceuticals, nutraceuticals, medical devices, wound care products, and compounding pharmacy services exclusively through licensed veterinary clinics across Canada. Founded in 2015 by veterinarian Dr. Ian Sandler and headquartered in Toronto, the company operates two reporting segments: Animal Health (USD 13.0 million in 2025 revenue, +7.4% YoY) and Compounding Pharmacy (USD 22.7 million in 2025 revenue, +54.7% YoY), with consolidated full-year 2025 revenue of $35.8 million and adjusted EBITDA of $6.9 million (+61.0%). The company has been cash-flow positive since 2021 and trades on the TSX-V under ticker WOLF.

The company's product portfolio is sourced through exclusive Canadian distribution agreements with global animal health manufacturers rather than proprietary R&D, including Orion Pharma Animal Health (Sileo, Bonqat), Vetpharma Animal Health (Sedaject, Ataject), VetriSCIENCE Pro Line (VetriFlex, Renal Essentials Pro, Composure Pro), Cf Pharma (GI Portfolio), Advancis Veterinary / Milliken (Activon Manuka Honey wound care), Nipro (IV catheters), Neogen (Ideal syringes), Lloyd (Thyro-Tabs), and MPS (protective wear). Through the compounding pharmacy vertical, the company operates Trutina Pharmacy (acquired 2021, equine specialization) and the Compounding Pharmacy of Manitoba (acquired December 2024 for USD 22.5 million), providing customized pharmaceutical formulations. Products are authorized by Health Canada.

The business model is prescription-driven and channel-mediated: Grey Wolf does not sell direct to consumers and prices are quote-based via territory managers and a "Request a Call" mechanism. Go-to-market is enterprise field sales, with territory managers calling on veterinary clinics organized by region (e.g., GTA Ontario, Southern Ontario), supported by educational webinars on CommuniVET and CE-accredited content. In 2026, the company announced a planned rebrand to Grey Wolf Health Corp. to reflect its broadened focus beyond animal health.

Short descriptiontext

Grey Wolf Animal Health is a Canadian specialty animal health company that distributes pharmaceuticals, nutraceuticals, wound care products, medical devices, and compounding pharmacy services to veterinary clinics nationwide, operating through acquired pharmacy subsidiaries and exclusive manufacturer distribution agreements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOakville, Canada
HQ citystring
Oakville
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal health products, veterinary pharmaceuticals, compounding pharmacy services, veterinary nutraceuticals, wound care products
Industry5 codes
PRIMARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMALAO
Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine)
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)
SECONDARYHLAMAEAF
Pain Management, Anesthesia & Critical Care Drugs
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAIAD
Compounding Pharmacies (Veterinary)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Specialty Animal Health Distribution
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Animal Health Product Sales
TypeOne Time License
Description

The company generates revenue through the sale of animal health products including pharmaceuticals (Bonqat, Sileo, Sedaject, Ataject, Lloyd Thyro-Tabs), nutraceuticals (VetriFlex, Composure Pro, HepatiClear, Renal Essentials Pro, L-Lysine Pro, GI Portfolio, MicroSilver+), medical devices (wound care products, IV catheters, syringes, protective wear, cohesive bandages), and Hide & Treat medication-hiding treats. Revenue increased 7.4% to $13.0 million for the Animal Health segment in 2025.

newswire.ca
2Compounding Pharmacy Services
TypeSubscription Recurring
Description

The company operates compounding pharmacies (Trutina Pharmacy for equine market, Compounding Pharmacy of Manitoba acquired December 2024) providing customized pharmaceutical formulations. This segment grew 54.7% to $22.7 million in 2025, driven by organic growth and the full-year impact from the Manitoba acquisition.

newswire.ca
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Others
Pricing details1 tier
1Products sold through veterinary clinics via prescription
ModelOtherBilling cadenceOther
Notes

All pharmaceutical products require veterinary prescription. Pricing is determined through veterinary clinic channels rather than public pricing pages.

greywolfah.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Trutina Pharmacy
Description

Independent Canadian compounding pharmacy specializing in formulation of innovative compounds for the equine market

greywolfah.com
+3 more records
Core offering1 text field

Grey Wolf Animal Health distributes and supplies specialty animal health products to veterinary clinics across Canada, including prescription pharmaceuticals (Bonqat, Sileo, Sedaject, Ataject, Lloyd Thyro-Tabs), nutraceuticals (VetriFlex, Composure Pro, GI Portfolio, Renal Essentials Pro), wound care products featuring 100% Medical Grade Manuka Honey (Activon, Actilite, Algivon), protective wear, syringes, and IV catheters. Through its wholly-owned Trutina Pharmacy and the Compounding Pharmacy of Manitoba, the company also provides customized compounded pharmaceutical formulations, particularly for the equine market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Revenue grew 33.3% year-over-year to $35.8 million in 2025
+3 more records
Product overview1 text field

Grey Wolf Animal Health is an animal health and wellness company that distributes a diversified portfolio of pharmaceutical, wound care, protective wear, nutraceutical, and disposable products for companion animals and horses in Canada. The core offering includes prescription pharmaceuticals (Bonqat®, Sileo®, Sedaject™, Ataject™, Lloyd Thyro-Tabs®), distributed from partners like Orion Pharma and Vetpharma; a wound care portfolio by Advancis Veterinary featuring Manuka Honey products (Activon®, Actilite®, Algivon®), absorbent dressings (Advazorb®, Eclypse®), and cohesive bandages; MPS Protective Wear as an e-collar alternative; and nutraceuticals including GI supplements, joint support (VetriFlex®), liver support (HepatiClear™ Pro), and behavior products (Composure™ Pro) from VetriSCIENCE and Cf Pharma. The company also operates a compounding pharmacy business (Trutina Pharmacy, Compounding Pharmacy of Manitoba) serving the equine and human compounding markets.

Product and service19 records
1Bonqat
CategoryPharmaceutical
Description

Pregabalin oral solution for cats indicated for anxiety-related anxiety; prescription medication available from veterinarians and distributed under partnership with Orion Pharma Animal Health.

2Sileo
CategoryPharmaceutical
Description

Dexmedetomidine hydrochloride oromucosal gel for dogs, used for noise aversion and sedation.

3Sedaject and Ataject Prescription Injectables
CategoryPharmaceutical
Description

Sedaject (dexmedetomidine hydrochloride injection, 0.5 mg/mL) and Ataject (atipamezole hydrochloride injection, 5.0 mg/mL) for sedation, analgesia, and reversal of dexmedetomidine sedation in animals.

4Lloyd Thyro-Tabs Canine
CategoryPharmaceutical
Description

Levothyroxine sodium tablets for canine hypothyroidism treatment, distributed from Lloyd, Inc.

5Activon Wound Care Line
CategoryWound Care
Description

100% Medical Grade Manuka Honey-based wound care portfolio including Activon Tube, Actilite (non-adherent viscose net dressing with 99% Manuka Honey and 1% Manuka oil), Algivon (alginate dressing), Advazorb (absorbent foam dressing), Eclypse Adherent and Eclypse Border (superabsorbent dressings), and Siltape (soft silicone perforated tape).

6Cohesive Bandages (COFLEX, PETFLEX, POWERFLEX)
CategoryWound Care
Description

Self-adhering elastic bandages for affixing, splinting and light compression in companion animals, distributed from Milliken Healthcare with EASYTEAR technology and NO CHEW variants.

7MPS Protective Wear (Medical Pet Shirts)
CategoryProtective Wear
Description

Animal-friendly alternative to e-collars including medical pet shirts for dogs, cats, and rabbits, plus boots, head covers, and leg sleeves, distributed from MPS International.

8GI Portfolio (Entero Aid +GI, Fibre Boost +GI, Pro Care +GI)
CategoryNutraceutical
Description

All-natural gastrointestinal health products including Entero Aid +GI (montmorillonite-based), Fibre Boost +GI (prebiotic/probiotic fiber supplement), and Pro Care +GI (synbiotic), distributed from Cf Pharma and authorized by Health Canada.

9Composure Pro
CategoryNutraceutical
Description

Behavioral support chew for cats and dogs containing Colostrum Calming Complex, Suntheanine L-Theanine, L-Tryptophan, and Thiamine to support relaxed behavior without a loading dose.

10VetriFlex
CategoryNutraceutical
Description

Clinical-strength joint support for dogs and cats with GlycOmega green-lipped mussel, Phytosome-powered curcumin and Boswellia to support cartilage development, mobility and flexibility.

11HepatiClear Pro
CategoryNutraceutical
Description

Liver support supplement for dogs with antioxidants supporting hepatic health and normal detoxification without requiring fasting.

12L-Lysine Pro
CategoryNutraceutical
Description

L-lysine and DMG blend supporting immune system function, eye and respiratory health in cats, authorized by Health Canada.

13Renal Essentials Pro
CategoryNutraceutical
Description

Kidney and immune support for cats and dogs with adaptogenic plant sources, antioxidants and essential vitamins and minerals to support normal renal circulation and detoxification.

14Hide and Treat
CategoryNutraceutical
Description

All-natural, stress-free soft chew for hiding medication in pets, low in fat and calories, available in duck, peanut butter & banana, or turkey & pumpkin flavors.

15MicroSilver+ Shampoo
CategoryNutraceutical
Description

Skin-soothing shampoo with MicroSilver BG active ingredient (0.2% silver concentration) that supports natural skin defenses and maintains healthy skin barrier.

16Ideal Instruments Syringes and Needles
CategoryDisposable Medical Device
Description

Disposable needles and syringes by Neogen for veterinary use featuring clear polypropylene barrel, silicone lubrication, ultra-sharp tri-beveled anti-coring needles, and ISO color-coded hubs.

17Nipro IV Catheters
CategoryDisposable Medical Device
Description

IV catheters by Nipro Medical Corporation featuring ETFE biocompatible material, smooth catheter-to-needle transition for atraumatic insertion, radiopaque construction, and color-coded hubs for rapid size identification.

18Trutina Pharmacy Equine Compounding Services
CategoryCompounding Pharmacy Services
Description

Customized pharmaceutical compounding services specializing in innovative formulations for the equine market, acquired in 2021 as Grey Wolf's equine compounding subsidiary.

19Compounding Pharmacy of Manitoba
CategoryCompounding Pharmacy Services
Description

Compounding pharmacy services acquired by Grey Wolf in December 2024 for USD 22.5 million, contributing to pharmacy business revenue growth of 54.7% to $22.7 million in 2025.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-31
Description

Acquired in December 2024 for USD 22.5 million, The Compounding Pharmacy of Manitoba expanded Grey Wolf's compounding pharmacy capabilities. This acquisition contributed to pharmacy business revenue growing 54.7% to $22.7 million in 2025.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-12-31
Description

Acquired in 2021, Trutina Pharmacy is an independent Canadian compounding pharmacy specializing in innovative formulations for the equine market. This acquisition expanded Grey Wolf's presence in the specialized equine pharmaceutical compounding space.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Advancis Veterinary wound care products including Activon Manuka Honey products (Activon Tube, Actilite, Algivon), absorbent dressings (Advazorb, Eclypse), and Siltape silicone tape. Products are 100% medical grade Manuka honey-based wound care solutions.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Nipro IV catheters. The catheters feature ETFE biocompatible material, smooth catheter-to-needle transition for atraumatic insertion, radiopaque construction, and color-coded hubs for rapid size identification.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Ideal Instruments syringes and needles by Neogen. Products include clear polypropylene syringes with silicone lubrication and ultra-sharp tri-beveled anti-coring needles with ISO color-coded hubs.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of VetriSCIENCE Pro Line nutraceuticals including VetriFlex (joint support), Renal Essentials Pro (kidney support), L-Lysine Pro (immune support), HepatiClear Pro (liver support), and Composure Pro (behavior support).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Cf Pharma GI products including Entero Aid +GI (gut health), Fibre Boost +GI (fiber supplement), and Pro Care +GI (synbiotic). These products support the company's educational message about reducing antimicrobial use in GI conditions.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of MPS (Medical Pet Shirts) protective wear, an animal-friendly alternative to the e-collar. Products include medical pet shirts for dogs, cats, and rabbits, as well as boots, head covers, and leg sleeves.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Milliken Healthcare cohesive bandages including COFLEX (10 lb), PETFLEX (15 lb), and POWERFLEX (23 lb) with EASYTEAR technology. NO CHEW variants feature bitter taste to prevent chewing.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Lloyd Thyro-Tabs Canine (levothyroxine sodium) for thyroid condition management in dogs.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Sedaject (dexmedetomidine hydrochloride injection) and Ataject (atipamezole hydrochloride injection) by Vetpharma for sedation and anesthesia reversal in animals.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Grey Wolf Animal Health is the Canadian distributor of Orion Pharma products including Sileo (dexmedetomidine oromucosal gel for anxiety) and Bonqat (pregabalin oral solution for cats). These are registered trademarks of Orion Pharma Animal Health.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global specialty animal health pharmaceutical company with a portfolio of pharmaceuticals, nutraceuticals, and veterinary specialty products. Comparable because it focuses on identifying and commercializing specialty animal health therapeutics across multiple species, similar to Grey Wolf's "unmet needs" thesis.

TypeDirect peer
Description

Independent global animal health company focused on pharmaceuticals, vaccines, and diagnostic services for companion and production animals. Comparable because Virbac competes in specialty veterinary therapeutics and nutraceuticals with similar channel strategy targeting veterinarians.

TypeDirect peer
Description

Specialty veterinary pharmaceuticals and products company focused on therapeutic areas like endocrinology, dermatology, and analgesia. Direct peer because of similar specialty therapeutics portfolio and veterinary channel focus; recently subject to take-private discussions validating the consolidation thesis.

TypeBroad incumbent
Description

World's largest animal health company with broad portfolio across pharmaceuticals, vaccines, diagnostics, and medicated feed. Comparable because Zoetis sells many of the same therapeutic categories (anesthesia, pain management, dermatology) through the veterinary channel that Grey Wolf distributes.

TypeBroad incumbent
Description

Major global animal health company offering pharmaceuticals, vaccines, and pet wellness products across companion animal and livestock markets. Comparable as a broad incumbent in the same veterinary channel with overlapping therapeutic categories.

TypeRegional player
Description

Canadian veterinary distributor serving veterinary clinics across Canada with pharmaceuticals, supplies, and pet foods. Direct comparable as a Canadian specialty veterinary distribution competitor with overlapping customer base of veterinary clinics.

TypeRegional player
Description

Canadian veterinary distribution cooperative supplying pharmaceuticals and supplies to member veterinary clinics. Comparable as a Canadian veterinary channel distributor; competes for the same veterinary clinic relationships.

TypeBroad incumbent
Description

Global animal health and mineral nutrition company focused on pharmaceuticals, vaccines, and nutritional specialties. Comparable in animal health distribution model and veterinary channel relationships, though with broader production animal exposure.

TypeOthers
Description

Largest Canadian pharmaceutical manufacturer with generic drugs, sterile injectables, and compounding pharmacy operations (through Apotex's compounding arm). Comparable for the compounding pharmacy segment, though not in the veterinary channel.

TypeOthers
Description

Canadian specialty pharmaceutical company with compounding pharmacy capabilities and a portfolio of niche therapeutics. Comparable for the compounding pharmacy operations segment of Grey Wolf's business, though primarily human-focused.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Grey Wolf Animal Health

Specialty Animal Health Distributiongreywolfah.com

Grey Wolf Animal Health is a Canadian specialty animal health company that distributes pharmaceuticals, nutraceuticals, wound care products, medical devices, and compounding pharmacy services to veterinary clinics nationwide, operating through acquired pharmacy subsidiaries and exclusive manufacturer distribution agreements.

What Grey Wolf Animal Health does

Grey Wolf Animal Health is a Canadian specialty animal health company that distributes pharmaceuticals, nutraceuticals, medical devices, wound care products, and compounding pharmacy services exclusively through licensed veterinary clinics across Canada. Founded in 2015 by veterinarian Dr. Ian Sandler and headquartered in Toronto, the company operates two reporting segments: Animal Health (USD 13.0 million in 2025 revenue, +7.4% YoY) and Compounding Pharmacy (USD 22.7 million in 2025 revenue, +54.7% YoY), with consolidated full-year 2025 revenue of $35.8 million and adjusted EBITDA of $6.9 million (+61.0%). The company has been cash-flow positive since 2021 and trades on the TSX-V under ticker WOLF.

The company's product portfolio is sourced through exclusive Canadian distribution agreements with global animal health manufacturers rather than proprietary R&D, including Orion Pharma Animal Health (Sileo, Bonqat), Vetpharma Animal Health (Sedaject, Ataject), VetriSCIENCE Pro Line (VetriFlex, Renal Essentials Pro, Composure Pro), Cf Pharma (GI Portfolio), Advancis Veterinary / Milliken (Activon Manuka Honey wound care), Nipro (IV catheters), Neogen (Ideal syringes), Lloyd (Thyro-Tabs), and MPS (protective wear). Through the compounding pharmacy vertical, the company operates Trutina Pharmacy (acquired 2021, equine specialization) and the Compounding Pharmacy of Manitoba (acquired December 2024 for USD 22.5 million), providing customized pharmaceutical formulations. Products are authorized by Health Canada.

The business model is prescription-driven and channel-mediated: Grey Wolf does not sell direct to consumers and prices are quote-based via territory managers and a "Request a Call" mechanism. Go-to-market is enterprise field sales, with territory managers calling on veterinary clinics organized by region (e.g., GTA Ontario, Southern Ontario), supported by educational webinars on CommuniVET and CE-accredited content. In 2026, the company announced a planned rebrand to Grey Wolf Health Corp. to reflect its broadened focus beyond animal health.

Grey Wolf Animal Health firmographics

Firmographics
Name
Grey Wolf Animal Health
Legal name
Grey Wolf Animal Health Inc.
Website
https://greywolfah.com
Company type
Public
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Grey Wolf Animal Health is a Canadian specialty animal health company that distributes pharmaceuticals, nutraceuticals, wound care products, medical devices, and compounding pharmacy services to veterinary clinics nationwide, operating through acquired pharmacy subsidiaries and exclusive manufacturer distribution agreements.
Ownership category
akta.pro rank

Grey Wolf Animal Health industry classification

Industry
Product category
Specialty Animal Health Distribution
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMALAO
Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine)
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)
SECONDARYHLAMAEAF
Pain Management, Anesthesia & Critical Care Drugs
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAIAD
Compounding Pharmacies (Veterinary)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)

Keywords

  • Animal health products
  • Veterinary pharmaceuticals
  • Compounding pharmacy services
  • Veterinary nutraceuticals
  • Wound care products

Where Grey Wolf Animal Health is headquartered

Location

Headquarters

HQ city
Oakville
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Grey Wolf Animal Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. Animal Health Product Sales: The company generates revenue through the sale of animal health products including pharmaceuticals (Bonqat, Sileo, Sedaject, Ataject, Lloyd Thyro-Tabs), nutraceuticals (VetriFlex, Composure Pro, HepatiClear, Renal Essentials Pro, L-Lysine Pro, GI Portfolio, MicroSilver+), medical devices (wound care products, IV catheters, syringes, protective wear, cohesive bandages), and Hide & Treat medication-hiding treats. Revenue increased 7.4% to $13.0 million for the Animal Health segment in 2025.
  2. Compounding Pharmacy Services: The company operates compounding pharmacies (Trutina Pharmacy for equine market, Compounding Pharmacy of Manitoba acquired December 2024) providing customized pharmaceutical formulations. This segment grew 54.7% to $22.7 million in 2025, driven by organic growth and the full-year impact from the Manitoba acquisition.

Pricing tiers

ModelBillingPrice
OtherOtherProducts sold through veterinary clinics via prescription

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Grey Wolf Animal Health product offering

Product offering

Core offering

Grey Wolf Animal Health distributes and supplies specialty animal health products to veterinary clinics across Canada, including prescription pharmaceuticals (Bonqat, Sileo, Sedaject, Ataject, Lloyd Thyro-Tabs), nutraceuticals (VetriFlex, Composure Pro, GI Portfolio, Renal Essentials Pro), wound care products featuring 100% Medical Grade Manuka Honey (Activon, Actilite, Algivon), protective wear, syringes, and IV catheters. Through its wholly-owned Trutina Pharmacy and the Compounding Pharmacy of Manitoba, the company also provides customized compounded pharmaceutical formulations, particularly for the equine market.

Product overview

Grey Wolf Animal Health is an animal health and wellness company that distributes a diversified portfolio of pharmaceutical, wound care, protective wear, nutraceutical, and disposable products for companion animals and horses in Canada. The core offering includes prescription pharmaceuticals (Bonqat®, Sileo®, Sedaject™, Ataject™, Lloyd Thyro-Tabs®), distributed from partners like Orion Pharma and Vetpharma; a wound care portfolio by Advancis Veterinary featuring Manuka Honey products (Activon®, Actilite®, Algivon®), absorbent dressings (Advazorb®, Eclypse®), and cohesive bandages; MPS Protective Wear as an e-collar alternative; and nutraceuticals including GI supplements, joint support (VetriFlex®), liver support (HepatiClear™ Pro), and behavior products (Composure™ Pro) from VetriSCIENCE and Cf Pharma. The company also operates a compounding pharmacy business (Trutina Pharmacy, Compounding Pharmacy of Manitoba) serving the equine and human compounding markets.

Differentiator

Problem solved

Functional benefit

Brands

  • Trutina Pharmacy: Independent Canadian compounding pharmacy specializing in formulation of innovative compounds for the equine market
  • GI Portfolio
  • Activon
  • Composure Pro

Products and services

  • Bonqat Pregabalin oral solution for cats indicated for anxiety-related anxiety; prescription medication available from veterinarians and distributed under partnership with Orion Pharma Animal Health.
  • Sileo Dexmedetomidine hydrochloride oromucosal gel for dogs, used for noise aversion and sedation.
  • Sedaject and Ataject Prescription Injectables Sedaject (dexmedetomidine hydrochloride injection, 0.5 mg/mL) and Ataject (atipamezole hydrochloride injection, 5.0 mg/mL) for sedation, analgesia, and reversal of dexmedetomidine sedation in animals.
  • Lloyd Thyro-Tabs Canine Levothyroxine sodium tablets for canine hypothyroidism treatment, distributed from Lloyd, Inc.
  • Activon Wound Care Line 100% Medical Grade Manuka Honey-based wound care portfolio including Activon Tube, Actilite (non-adherent viscose net dressing with 99% Manuka Honey and 1% Manuka oil), Algivon (alginate dressing), Advazorb (absorbent foam dressing), Eclypse Adherent and Eclypse Border (superabsorbent dressings), and Siltape (soft silicone perforated tape).
  • Cohesive Bandages (COFLEX, PETFLEX, POWERFLEX) Self-adhering elastic bandages for affixing, splinting and light compression in companion animals, distributed from Milliken Healthcare with EASYTEAR technology and NO CHEW variants.
  • MPS Protective Wear (Medical Pet Shirts) Animal-friendly alternative to e-collars including medical pet shirts for dogs, cats, and rabbits, plus boots, head covers, and leg sleeves, distributed from MPS International.
  • GI Portfolio (Entero Aid +GI, Fibre Boost +GI, Pro Care +GI) All-natural gastrointestinal health products including Entero Aid +GI (montmorillonite-based), Fibre Boost +GI (prebiotic/probiotic fiber supplement), and Pro Care +GI (synbiotic), distributed from Cf Pharma and authorized by Health Canada.
  • Composure Pro Behavioral support chew for cats and dogs containing Colostrum Calming Complex, Suntheanine L-Theanine, L-Tryptophan, and Thiamine to support relaxed behavior without a loading dose.
  • VetriFlex Clinical-strength joint support for dogs and cats with GlycOmega green-lipped mussel, Phytosome-powered curcumin and Boswellia to support cartilage development, mobility and flexibility.
  • HepatiClear Pro Liver support supplement for dogs with antioxidants supporting hepatic health and normal detoxification without requiring fasting.
  • L-Lysine Pro L-lysine and DMG blend supporting immune system function, eye and respiratory health in cats, authorized by Health Canada.
  • Renal Essentials Pro Kidney and immune support for cats and dogs with adaptogenic plant sources, antioxidants and essential vitamins and minerals to support normal renal circulation and detoxification.
  • Hide and Treat All-natural, stress-free soft chew for hiding medication in pets, low in fat and calories, available in duck, peanut butter & banana, or turkey & pumpkin flavors.
  • MicroSilver+ Shampoo Skin-soothing shampoo with MicroSilver BG active ingredient (0.2% silver concentration) that supports natural skin defenses and maintains healthy skin barrier.
  • Ideal Instruments Syringes and Needles Disposable needles and syringes by Neogen for veterinary use featuring clear polypropylene barrel, silicone lubrication, ultra-sharp tri-beveled anti-coring needles, and ISO color-coded hubs.
  • Nipro IV Catheters IV catheters by Nipro Medical Corporation featuring ETFE biocompatible material, smooth catheter-to-needle transition for atraumatic insertion, radiopaque construction, and color-coded hubs for rapid size identification.
  • Trutina Pharmacy Equine Compounding Services Customized pharmaceutical compounding services specializing in innovative formulations for the equine market, acquired in 2021 as Grey Wolf's equine compounding subsidiary.
  • Compounding Pharmacy of Manitoba Compounding pharmacy services acquired by Grey Wolf in December 2024 for USD 22.5 million, contributing to pharmacy business revenue growth of 54.7% to $22.7 million in 2025.

Quantifiable outcome

  • Revenue grew 33.3% year-over-year to $35.8 million in 2025
  • +3 more outcomes

Companies that use Grey Wolf Animal Health

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Grey Wolf Animal Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Grey Wolf Animal Health partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • The Compounding Pharmacy of ManitobacoreStrategic or Co-development Partner · 31 December 2024Acquired in December 2024 for USD 22.5 million, The Compounding Pharmacy of Manitoba expanded Grey Wolf's compounding pharmacy capabilities. This acquisition contributed to pharmacy business revenue growing 54.7% to $22.7 million in 2025.
  • Trutina PharmacycoreStrategic or Co-development Partner · 31 December 2021Acquired in 2021, Trutina Pharmacy is an independent Canadian compounding pharmacy specializing in innovative formulations for the equine market. This acquisition expanded Grey Wolf's presence in the specialized equine pharmaceutical compounding space.
  • Advancis Veterinary (Milliken)coreChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Advancis Veterinary wound care products including Activon Manuka Honey products (Activon Tube, Actilite, Algivon), absorbent dressings (Advazorb, Eclypse), and Siltape silicone tape. Products are 100% medical grade Manuka honey-based wound care solutions.
  • Nipro Medical CorporationminorChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Nipro IV catheters. The catheters feature ETFE biocompatible material, smooth catheter-to-needle transition for atraumatic insertion, radiopaque construction, and color-coded hubs for rapid size identification.
  • Neogen (Ideal Instruments)minorChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Ideal Instruments syringes and needles by Neogen. Products include clear polypropylene syringes with silicone lubrication and ultra-sharp tri-beveled anti-coring needles with ISO color-coded hubs.
  • VetriSCIENCE Pro LinecoreChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of VetriSCIENCE Pro Line nutraceuticals including VetriFlex (joint support), Renal Essentials Pro (kidney support), L-Lysine Pro (immune support), HepatiClear Pro (liver support), and Composure Pro (behavior support).
  • Cf PharmacoreChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Cf Pharma GI products including Entero Aid +GI (gut health), Fibre Boost +GI (fiber supplement), and Pro Care +GI (synbiotic). These products support the company's educational message about reducing antimicrobial use in GI conditions.
  • MPS InternationalminorChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of MPS (Medical Pet Shirts) protective wear, an animal-friendly alternative to the e-collar. Products include medical pet shirts for dogs, cats, and rabbits, as well as boots, head covers, and leg sleeves.
  • Milliken HealthcareminorChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Milliken Healthcare cohesive bandages including COFLEX (10 lb), PETFLEX (15 lb), and POWERFLEX (23 lb) with EASYTEAR technology. NO CHEW variants feature bitter taste to prevent chewing.
  • Lloyd, Inc.minorChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Lloyd Thyro-Tabs Canine (levothyroxine sodium) for thyroid condition management in dogs.
  • Vetpharma Animal Health S.L.minorChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Sedaject (dexmedetomidine hydrochloride injection) and Ataject (atipamezole hydrochloride injection) by Vetpharma for sedation and anesthesia reversal in animals.
  • Orion Pharma Animal HealthcoreChannel Partner/ Reseller/ DistributorGrey Wolf Animal Health is the Canadian distributor of Orion Pharma products including Sileo (dexmedetomidine oromucosal gel for anxiety) and Bonqat (pregabalin oral solution for cats). These are registered trademarks of Orion Pharma Animal Health.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Grey Wolf Animal Health competitors and assessment

Company assessment

Direct peers

  • Vetoquinol: Global specialty animal health pharmaceutical company with a portfolio of pharmaceuticals, nutraceuticals, and veterinary specialty products. Comparable because it focuses on identifying and commercializing specialty animal health therapeutics across multiple species, similar to Grey Wolf's "unmet needs" thesis.
  • Virbac: Independent global animal health company focused on pharmaceuticals, vaccines, and diagnostic services for companion and production animals. Comparable because Virbac competes in specialty veterinary therapeutics and nutraceuticals with similar channel strategy targeting veterinarians.
  • Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals and products company focused on therapeutic areas like endocrinology, dermatology, and analgesia. Direct peer because of similar specialty therapeutics portfolio and veterinary channel focus; recently subject to take-private discussions validating the consolidation thesis.

Broad incumbents

  • Zoetis: World's largest animal health company with broad portfolio across pharmaceuticals, vaccines, diagnostics, and medicated feed. Comparable because Zoetis sells many of the same therapeutic categories (anesthesia, pain management, dermatology) through the veterinary channel that Grey Wolf distributes.
  • Elanco Animal Health: Major global animal health company offering pharmaceuticals, vaccines, and pet wellness products across companion animal and livestock markets. Comparable as a broad incumbent in the same veterinary channel with overlapping therapeutic categories.
  • Phibro Animal Health: Global animal health and mineral nutrition company focused on pharmaceuticals, vaccines, and nutritional specialties. Comparable in animal health distribution model and veterinary channel relationships, though with broader production animal exposure.

Regional players

  • CDMV: Canadian veterinary distributor serving veterinary clinics across Canada with pharmaceuticals, supplies, and pet foods. Direct comparable as a Canadian specialty veterinary distribution competitor with overlapping customer base of veterinary clinics.
  • Veterinary Purchasing Company: Canadian veterinary distribution cooperative supplying pharmaceuticals and supplies to member veterinary clinics. Comparable as a Canadian veterinary channel distributor; competes for the same veterinary clinic relationships.

Others

  • Apotex: Largest Canadian pharmaceutical manufacturer with generic drugs, sterile injectables, and compounding pharmacy operations (through Apotex's compounding arm). Comparable for the compounding pharmacy segment, though not in the veterinary channel.
  • Avrio Health (Pharmascience): Canadian specialty pharmaceutical company with compounding pharmacy capabilities and a portfolio of niche therapeutics. Comparable for the compounding pharmacy operations segment of Grey Wolf's business, though primarily human-focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Grey Wolf Animal Health social profiles

Digital presence

Grey Wolf Animal Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Grey Wolf Animal Health leadership team

Management profile

Number of profiles

Profiles7 records

Grey Wolf Animal Health subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Grey Wolf Animal Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Grey Wolf Animal Health M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grey Wolf Animal Health

What does Grey Wolf Animal Health do?

Grey Wolf Animal Health distributes and supplies specialty animal health products to veterinary clinics across Canada, including prescription pharmaceuticals (Bonqat, Sileo, Sedaject, Ataject, Lloyd Thyro-Tabs), nutraceuticals (VetriFlex, Composure Pro, GI Portfolio, Renal Essentials Pro), wound care products featuring 100% Medical Grade Manuka Honey (Activon, Actilite, Algivon), protective wear, syringes, and IV catheters. Through its wholly-owned Trutina Pharmacy and the Compounding Pharmacy of Manitoba, the company also provides customized compounded pharmaceutical formulations, particularly for the equine market.

Is Grey Wolf Animal Health a public or private company?

Grey Wolf Animal Health is a public company. It is classified as public and is currently operating.

When was Grey Wolf Animal Health founded?

Grey Wolf Animal Health was founded in 2015. It employs 11 to 50 people.

Where is Grey Wolf Animal Health based?

Grey Wolf Animal Health is headquartered in Oakville, Canada, in the North America region.

How does Grey Wolf Animal Health make money?

Two revenue lines are on record. Animal Health Product Sales are the primary driver. The others are compounding Pharmacy Services.

Who are Grey Wolf Animal Health's main competitors?

Direct peers on record are Vetoquinol, Virbac and Dechra Pharmaceuticals. Broad incumbents are Zoetis, Elanco Animal Health and Phibro Animal Health. Regional players are CDMV and Veterinary Purchasing Company. Others are Apotex and Avrio Health (Pharmascience).

Does Grey Wolf Animal Health have an API?

No public API is recorded for Grey Wolf Animal Health.

What industry is Grey Wolf Animal Health in?

Grey Wolf Animal Health's product category is Specialty Animal Health Distribution. Its primary akta.pro industry code is HLAMAIAH, Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology), with a secondary code of HLAMALAO, Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine). Its NAICS code is 325414 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooGREY WOLF HEALTH TO PRESENT AT THE SMALLCAP DISCOVERIES 2026 INVESTOR CONFERENCEGrey Wolf Health Corp. announced CEO Angela Cechetto will present a corporate update at the Smallcap Discoveries 2026 Investor Conference on September 29, 2026, in Vancouver. She will also be available for one-on-one meetings on September 28-29, 2026.NewswireGREY WOLF HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTSGrey Wolf Health reported Q2 2026 revenue of $10.6 million, up 11.1% year over year, and adjusted EBITDA of $2.0 million, down 7.5%. The company also reported six-month revenue of $19.3 million and adjusted EBITDA of $3.5 million, up 1.3%.TalkMarketsAnimal Drug Compounding Market Trends in Flavor-Enhanced Veterinary DrugsThe global animal drug compounding market was valued at USD 1.7 billion in 2025 and is projected to grow to USD 3.3 billion by 2033, registering a CAGR of 8.5%, driven by rising pet ownership and demand for personalized veterinary medications. North America held the largest regional revenue share of 37.2% in 2025, while Asia Pacific is expected to register the highest growth rate during the forecast period. The market is consolidating through strategic acquisitions, including Grey Wolf Animal Health Corp.'s purchase of the Compounding Pharmacy of Manitoba in December 2024, as companies expand compounding capabilities and distribution networks.AInvestGrey Wolf Animal Health Corp. announces name change to Grey Wolf Health Corp.Grey Wolf Animal Health Corp. announced a corporate name change to Grey Wolf Health Corp., reflecting its strategic expansion beyond animal health into broader human health markets. The company reported strong fourth quarter and full-year 2025 financial results, with revenue increasing 34.3% year-over-year to $9.0 million for the quarter and 33.3% to $35.8 million for the full year, while adjusted EBITDA rose 79.3% to $1.6 million for Q4. To support its growth strategy, Grey Wolf appointed Susan Bodner as Vice President of Sales & Marketing, with the company noting the pharmacy business grew 54.7% to $22.7 million for the year, driven by organic growth and the full-year impact of the CPM Acquisition.NewswireGREY WOLF ANIMAL HEALTH CORP. ANNOUNCES NAME CHANGE TO GREY WOLF HEALTH CORP.Grey Wolf Animal Health Corp. changed its name to Grey Wolf Health Corp. effective June 30, 2026, with new CUSIP and ISIN assigned. The company's ticker symbol remains unchanged on the TSX Venture Exchange. The name reflects its expanded platform serving both human and animal health markets.NewswireGREY WOLF ANIMAL HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSGrey Wolf Animal Health reported Q1 2026 revenue of $8.8 million, up 10.5% year-over-year, and adjusted EBITDA of $1.5 million, up 16.6%. The company set a five-year target to organically double adjusted EBITDA by 2030 and is pursuing acquisition opportunities.NewswireGREY WOLF ANIMAL HEALTH REPORTS FOURTH QUARTER AND YEAR END 2025 FINANCIAL RESULTSGrey Wolf Animal Health Corp. reported strong fourth quarter and full year 2025 financial results, with revenue increasing 33.3% year over year to $35.8 million and Adjusted EBITDA rising 61.0% to $6.9 million for the year. The company's pharmacy business revenue grew 54.7% to $22.7 million, driven by organic growth and the full-year impact from the acquisition of The Compounding Pharmacy of Manitoba in December 2024, while the Animal Health business increased 7.4% to $13.0 million. The company also announced plans to change its name to Grey Wolf Health Corp. to reflect its expanded focus beyond animal health.NewswireGREY WOLF ANIMAL HEALTH APPOINTS A VICE PRESIDENT, SALES & MARKETING TO ADVANCE COMMERCIAL STRATEGYGrey Wolf Animal Health appointed Susan Bodner as Vice President Sales & Marketing, effective April 13, 2026. She brings over 15 years of experience in sales and marketing, including senior roles in the medical device industry. She will lead commercial strategy for both pharmacy and animal health business units.Nova One AdvisorCompounding Pharmacies Market to Reach Around USD 35.81 Bn by 2035The global compounding pharmacies market was valued at USD 18.5 billion in 2025 and is projected to reach approximately USD 35.81 billion by 2035, growing at a compound annual growth rate of 6.83%. North America led the market with a 50% share in 2025, driven by demand for personalized medicine, chronic disease management, and supportive regulatory frameworks such as the Drug Quality and Security Act. Key industry players profiled include Walgreens Co., Fagron, Albertsons Companies, and multiple independent compounding pharmacies, with notable recent developments including Grey Wolf Animal Health Corp's acquisition of the Compounding Pharmacy of Manitoba for USD 22.5 million and Eli Lilly's expanded dosing plans for Zepbound following an FDA-declared shortage.NewswireGREY WOLF ANIMAL HEALTH REPORTS THIRD QUARTER 2025 FINANCIAL RESULTSGrey Wolf Animal Health Corp. reported Q3 2025 financial results with revenue increasing 35.3% year over year to $9.3 million and adjusted EBITDA rising 62.3% to $1.9 million. The company's Pharmacy business was the primary growth driver, with revenue up 52.4% to $5.8 million due to organic growth and the acquisition of Compounding Pharmacy of Manitoba in December 2024, while the Animal Health business grew 14.5% to $3.6 million. Year to date, the company generated $2.3 million in cash from operations and held $6.7 million in cash against $25.5 million in outstanding borrowings.